NovaBay Pharma (NBY) Receives $1.5M of Additional Financing Via Equity Offering
Tweet Send to a Friend
NovaBay Pharmaceuticals, Inc. (NYSE: NBY), announced the receipt of a $1.5 million equity investment from Pioneer Pharma (Singapore) Pte. Ltd., an affiliate of Naqu Area Pioneer Pharma Co., Ltd., a Shanghai-based company that markets high-end pharmaceutical products into China. As part of the expansion of the NeutroPhase distribution agreement for Southeast Asia announced on September 14, 2012, Pioneer has completed its investment of $2.5 million. Pioneer has the right to invest an additional $3.0 Million on or before August 31, 2013.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NovaBay Supports Legislation to Attack Antibiotic Resistance
- Ashford Hospitality Trust (AHT) Plans to Spin High RevPAR Hotel Portfolio
- Yongye (YONG) to Resume Trading on Nasdaq; CEO Wu Shows Continued Interest
Create E-mail Alert Related Categories
Corporate News, Market Check
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
